We hypothesized that LSD2 is an epigenetic enzyme critical for cell proliferation and oncogenic transformation of Ewing sarcoma cells, and predicted that SP-2509 inhibits not only LSD1, but also LSD2. This evidence concerns the gene KDM1B and Ewing sarcoma.